Skip to main content

Table 1 Demographic characteristics and biochemical data for patients with impaired fasting glucose (IFG), patients with impaired glucose tolerance (IGT), and control subjects

From: Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism

  IFG (n = 29) IGT (n = 29) Control (n = 28) p
Gender, n (%)     
   Female 23 (79.3) 23 (79.3) 23 (82.1) 0.953
   Male 6 (20.7) 6 (20.7) 5 (17.9)  
Age (Years), mean ± SD 45.2 ± 10.3 46.9 ± 10.4 44.2 ± 8.1 0.575
BMI (kg/m 2 ), mean ± SD 27.9 ± 2.4 28.6 ± 3.6 28.6 ± 4.1 0.652
Waist/hip ratio, mean ± SD 0.90 ± 0.07 0.87 ± 0.07 0.85 ± 0.08 0.047
Hypertension, n (%)     
   Absent 28 (96.6) 27 (93.1) 28 (100.0) 0.770
   Present 1 (3.4) 2 (6.9) 0 (0)  
Smoking, n (%)     
   Absent 26 (89.7) 24 (82.8) 25 (89.3) 0.784
   Present 3 (10.3) 5 (17.2) 3 (10.7)  
Total cholesterol level (mg/dL), mean ± SD 184.9 ± 27.2 187.6 ± 34.9 198.1 ± 23.3 0.110
LDL level (mg/dL), mean ± SD 117.7 ± 40.3 105.9 ± 32.6 118.2 ± 23.7 0.204
HDL level (mg/dL), mean ± SD memean ± SD 47.9 ± 10.2 52.2 ± 27.3 51.3 ± 11.7 0.533
TG level (mg/dL), mean ± SD 120.9 ± 38.9 148.0 ± 68.9 131.6 ± 48.2 0.364
Fasting blood glucose level (mg/dL), mean ± SD 111.1 ± 5.9 105.1 ± 8.5 92.3 ± 5.0 <0.001
Insulin level, mean ± SD 11.9 ± 4.8 13.1 ± 5.4 9.10 ± 4.2 0.008
HOMA-IR level, mean ± SD 3.4 ± 1.4 4.1 ± 1.7 2.1 ± 1.0 <0.001
  1. HOMA-IR: Homeostatic model assessment BMI: Body mass ındex